Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.
Saved in:
| Title: | Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients. |
|---|---|
| Authors: | Thompson MA; Aurora Cancer Care, Advocate Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI,. Electronic address: michael.thompson@tempus.com., Boccadoro M; Division of Hematology, University of Torino, Torino, Italy., Leleu X; Pôle Régional de Cancérologie, Department of Hematology, CHU La Milétrie-Poitiers, Poitiers, France., Vela-Ojeda J; Department of Hematology, UMAE Hospital de Especialidades Centro Medico La Raza IMSS, Mexico City, Mexico., van Rhee F; University of Arkansas for Medical Sciences, Little Rock, AR., Weisel KC; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Rifkin RM; Rocky Mountain Cancer Centers/US Oncology Research, Denver, CO., Usmani SZ; Levine Cancer Institute, Charlotte, NC., Hájek R; Department of Hemato-oncology, University Hospital Ostrava, and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Cook G; Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK., Abonour R; Indiana University School of Medicine, Indianapolis, IN., Armour M; Mijelom CRO, Croatian Myeloma Support Association, Zagreb, Croatia., Morgan KE; Myeloma Patients Europe, Brussels, Belgium., Yeh SP; China Medical University Hospital, Taichung City, P.R.China., Costello CL; University of California San Diego, La Jolla, CA., Berdeja JG; Department of Hematology, Tennessee Oncology and Sarah Cannon Research Institute, Nashville, TN., Davies FE; Perlmutter Cancer Center, NYU Langone, New York, NY., Zonder JA; Department of Malignant Hematology, Barbara Ann Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI., Lee HC; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Omel J; The Central Nebraska Myeloma Support Group, Grand Island, NE., Spencer A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health Monash University, Melbourne, Australia., Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Hungria VTM; Department of Hematology, Clinica São Germano and Santa Casa Medical School, São Paulo, Brazil., Puig N; Hematology Department, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain., Fu C; First Affiliated Hospital, Soochow University, Suzhou Jiangsu, P.R.China., Ferrari RH; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA., Ren K; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA., Stull DM; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA., Chari A; Department of Hematology-Oncology, Mount Sinai School of Medicine, New York, NY. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Mar; Vol. 23 (3), pp. e171-e181. Date of Electronic Publication: 2022 Dec 07. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2152-2669 |
|---|---|
| DOI: | 10.1016/j.clml.2022.12.003 |
